ATYR PHARMA INC.

- USD (-)

- 15 min delayed data - NASDAQ Stocks

Open:	-
Change:	-
Volume:	-

Low:	-
High:	-
High / Low range:	-

Type:	Stocks
Ticker:	LIFE
ISIN:

ATYR PHARMA INC. overview

> Analyses

Londinia AI has published a new analysis for PawelBodytko.

0
72331
15104
0

ATYR PHARMA INC. - Weekly

Timeframe : Weekly - Simple chart
Status : IN PROGRESS...

The current short-term bullish acceleration on ATYR PHARMA INC. should quickly allow the basic trend to return to bullish. To avoid contradicting the short term, traders may prefer long positions (at…

Thank you Reply Chart

> Analyses

Londinia AI has published a new analysis for PawelBodytko.

0
72331
15104
0

ATYR PHARMA INC. - Daily

Timeframe : Daily - Simple chart
Status : TARGET REACHED

In the short term, there could be an acceleration of the basic bullish trend on ATYR PHARMA INC.. This is a positive signal for buyers. As long as the price remains above 1.35 USD, a purchase could be…

Thank you Reply Chart

> News PR Newswire published a news.

Thinking about buying stock in Eurocell, Maia Biotechnology, Figs, aTyr Pharma, or Bloom Energy? • • PR Newswire • Stocks • More ATYR PHARMA INC. news...

Thinking about buying stock in Eurocell, Maia Biotechnology, Figs, aTyr Pharma, or Bloom Energy? PR Newswire NEW YORK, Nov. 10, 2023 NEW YORK , Nov. 10, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ECEL, MAIA, FIGS, LIFE, and BE. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. ECEL:...

Thank you Chart

> News Newsfile Corp. published a news.

aTyr Pharma to Present at the Benzinga Biotech Small Cap Conference • • Newsfile Corp. • Stocks • More ATYR PHARMA INC. news...

San Diego, California--(Newsfile Corp. - March 19, 2021) - aTyr Pharma, Inc. (NASDAQ: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, today announced that Sanjay S. Shukla, M.D., M.S., President and Chief Executive Officer, will present a corporate overview and participate in live Q&A at the Benzinga Biotech Small Cap Conference, which is being held March 24 - 25, 2021 in a virtual format. Company management...

Thank you Chart

> News ClayTrader posted a new video.

aTyr Pharma, Inc. - LIFE Stock Chart Technical Analysis for 03-16-2021 • • ClayTrader • Stocks • More ATYR PHARMA INC. news...

...

Thank you Chart

> News ClayTrader posted a new video.

aTyr Pharma, Inc. - LIFE Stock Chart Technical Analysis for 01-06-2020 • • ClayTrader • Stocks • More ATYR PHARMA INC. news...

...

Thank you Chart

> News ClayTrader posted a new video.

aTyr Pharma, Inc. - LIFE Stock Chart Technical Analysis for 06-08-18 • • ClayTrader • Stocks • More ATYR PHARMA INC. news...

...

Thank you Chart

> News PR Newswire published a news.

aTyr Pharma Announces Appointment of Jeffery S. Hatfield to its Board of Directors • • PR Newswire • Stocks • More ATYR PHARMA INC. news...

aTyr Pharma Announces Appointment of Jeffery S. Hatfield to its Board of Directors PR Newswire SAN DIEGO, April 3, 2017 SAN DIEGO , April 3, 2017 /PRNewswire/ -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, today announced the appointment of Mr. Jeffrey S. Hatfield , as an independent board director, to aTyr Pharma's board of directors, effective immediately. Mr. Hatfield...

Thank you Chart

Load more content